Bausch & Lomb BLCO
NYSE BLCO
$17.24 +0.04 (+0.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Non-Current Deferred Tax Liability came in at $18.0 million in Q2 2026, up 28.57% YoY from $14.0 million in Q2 2025, and down 5.26% on a QoQ basis from $19.0 million in Q1 2026.

Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $18.0 million in Q2 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 28.57% year-over-year to $18.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.0 million (up 28.57% YoY) and the FY2025 annual result came in at $19.0 million, down 83.62% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $18.0 million in Q2 2026, from $19.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $118.0 million in Q4 2023 to a low of $10.0 million in Q2 2022.
  • A 5-year average of $36.1 million and a median of $14.0 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 120.75% — and 2023, when it slumped 86.41%.
  • Tracing BLCO's Non-Current Deferred Tax Liability over 5 years: stood at $117.0 million in 2022, then advanced by 0.85% to $118.0 million in 2023, then slipped by 1.69% to $116.0 million in 2024, then slumped by 83.62% to $19.0 million in 2025, then decreased by 5.26% to $18.0 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $18.0 million (Q2 2026), $19.0 million (Q1 2026), and $19.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Bausch & Lomb 6.14 Bn 5.76 Bn 867.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 18.00 Mn
Jun 30, 2026 18.00 Mn
Mar 31, 2026 19.00 Mn
Mar 31, 2026 19.00 Mn
Dec 31, 2025 19.00 Mn
Dec 31, 2025 19.00 Mn
Sep 30, 2025 14.00 Mn
Sep 30, 2025 14.00 Mn
Jun 30, 2025 14.00 Mn
Jun 30, 2025 14.00 Mn
Mar 31, 2025 13.00 Mn
Mar 31, 2025 13.00 Mn
Dec 31, 2024 116.00 Mn
Dec 31, 2024 116.00 Mn
Sep 30, 2024 12.00 Mn
Sep 30, 2024 12.00 Mn
Jun 30, 2024 14.00 Mn
Jun 30, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn